Rechercher des projets européens

31 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

European Human Biomonitoring Initiative (HBM4EU)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Voir le projet

 43

 TERMINÉ 
The new challenge in global health is to achieve Universal Health Care (UHC) by 2030. Having an adequate workforce is critical to achieving UHC. Efforts are in place to scale up the numbers of health workers. Improving health workforce performance is equally important as the quantity of health workers, but more challenging. Workforce performance improvement can be achieved better at management ...
Voir le projet

 7

 TERMINÉ 

Integrated Climate forcing and Air pollution Reduction in Urban Systems (ICARUS)

Date du début: 1 mai 2016, Date de fin: 30 avr. 2020,

ICARUS will develop innovative tools for urban impact assessment in support of air quality and climate change governance in the EU. This will lead to designing and implementing win-win strategies to improve the air quality and reduce the carbon footprint in European cities. An integrated approach will be used for air pollution monitoring and assessment combining ground-based measurements, atmosphe ...
Voir le projet

 18

 TERMINÉ 
Malaria is a life-threatening disease causing more than 500,000 deaths every year in sub-Saharan Africa. Prevention of the disease is best achieved by vector control which relies on the use of insecticides. Monitoring mosquito vector populations is an integral component of control programmes and a prerequisite for effective interventions. Several individual methods are used for this task, However, ...
Voir le projet

 10

 TERMINÉ 

Aging Lungs in European Cohorts (ALEC)

Date du début: 1 mai 2015, Date de fin: 30 avr. 2019,

This programme of work will advance the understanding of the combined effects of factors that cause poor lung function, respiratory disability and the development of COPD . This will be achieved by examination of determinants of lung growth and lung function decline within existing cohorts that cover the whole life course, and which have followed, in detail, the respiratory health status of over 2 ...
Voir le projet

 15

 TERMINÉ 

Anthelmintic Research and Optimization (A-HERO)

Date du début: 1 mai 2014, Date de fin: 30 avr. 2019,

"I propose an ambitious, yet feasible 5-year research project that will fill an important gap in global health. Specifically, I will develop and validate novel approaches for anthelmintic drug discovery and development. My proposal pursues the following five research questions: (i) Is a chip calorimeter suitable for high-throughput screening in anthelmintic drug discovery? (ii) Is combination chem ...
Voir le projet

 1

 TERMINÉ 
The EU population is increasingly exposed to new physical and chemical agents in the environment, some of which may be detrimental to public health. Of these, electromagnetic fields (EMF) are one of the most ubiquitous, with new EMF technologies and novel applications being actively developed and commercialised. To address pertinent questions on EMF and health, GERoNiMO proposes an integrated appr ...
Voir le projet

 27

 TERMINÉ 
The World Health Organisation in its report on Neglected Tropical Diseases has stated that there is overwhelming evidence to show that the burden caused by many of the 17 diseases that affect more than 1billion people worldwide can be effectively controlled and, in many cases, eliminated or even eradicated. Leishmaniasis caused by Leishmania spp is one of them and poses a grave health risk to an e ...
Voir le projet

 9

 TERMINÉ 

Innovative Modelling to Optimise Control of Childhood Anaemia across Africa (IMCCA)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,

"Anaemia affects two-third of all preschool-aged children in Africa. Malnutrition, malaria and helminth infections are among the main factors contributing to anaemia in this age group, however their relative contribution across the continent is not well understood. Spatially explicit estimates of anaemia risk are important measures of child morbidity and mortality.The goal of the project is to dev ...
Voir le projet

 1

 TERMINÉ 
"Multidrug-resistant bacteria are a global threat to public health and the economy. Studies in model organisms suggest compensatory evolution and epistatic interactions between drug resistance-conferring mutations are important drivers of drug resistance. However, the relevance of these factors for the emergence and transmission of human pathogenic bacteria has not been established. To bridge the ...
Voir le projet

 1

 TERMINÉ 
This project aims to predict individual disease risk related to the environment, by characterizing the external and internal exposome for common exposures (air and drinking water contaminants) during critical periods of life, including in utero. A large amount of health data is now available from longitudinal cohorts in both children and adults, with detailed information on risk factors, confounde ...
Voir le projet

 15

 TERMINÉ 

African Vector Control: New Tools (AvecNet)

Date du début: 1 févr. 2011, Date de fin: 31 déc. 2016,

The AvecNet consortium will develop practical solutions to the current limitations of vector control strategies in Africa using a combination of translationally-aware, state of the art science and end user analysis to ensure successful development and uptake of the new and improved approaches to malaria control and elimination. Our carefully balanced, multidisciplinary team of European and Africa ...
Voir le projet

 17

 TERMINÉ 

Kinetoplastid Drug Development: strengthening the preclinical pipeline (KINDRED)

Date du début: 1 sept. 2013, Date de fin: 31 août 2016,

The trypanosomatid diseases, leishmaniasis, Human African trypanosomiasis (HAT) and Chagas disease (CD), continue to impart a heavy toll on human health. The treatments available are limited and threatened by drug resistance with few newdrugs in the pipeline. The KINDReD consortium integrates five leading academic laboratories in Europe (Portugal, United Kingdom, and Switzerland), the USA (Califor ...
Voir le projet

 14

 TERMINÉ 
Current surveillance systems and control efforts are clearly insufficient to combat dengue in endemic countries and to prevent spread to previously uninfected areas (including Europe). We will focus on the following aspects of the call: better diagnosis, surveillance, prevention as well as prediction and/or prevention of the spread of Dengue fever to previously uninfected regions (including Europe ...
Voir le projet

 14

 TERMINÉ 
Neglected Infectious Diseases (NID) such as trypanosomiasis, leishmaniasis, schistosomiasis and soil-transmitted helminthiasis receive less than 5% of the global investment for tropical diseases research. Clinical praxis in disease-endemic countries (DEC) is rarely evidence based and does not make use of the latest innovations in diagnostic technology. NID–related research on diagnostics is partic ...
Voir le projet

 13

 TERMINÉ 
Humans and animals living in poor communities in the developing world often suffer from health problems arising from neglected zoonoses. Control options for these diseases are perceived as either too expensive or to be beyond the mandate of either the human or animal health systems. There is evidence that zoonoses in humans can be suppressed or even eliminated through interventions in animals. Mor ...
Voir le projet

 9

 TERMINÉ 
The proposal addresses the workforce deficit in sub-Saharan countries in Africa by improving the overall performance of the workforce. Management strengthening activities will be tested to identify what improvements can be made within available resources in decentralised management structures. The management strengthening activities will develop integrated approaches to improving workforce perfo ...
Voir le projet

 6

 TERMINÉ 
Worm infections are receiving increased attention due to: the wide geographic overlap in occurrence between worms and HIV, TB and malaria; the large proportion of individuals (minimal estimates around 25%) co-infected with worms and HIV/TB/ malaria; the potential risk of increasing disease burden; the very limited understanding of the impact by worm infections on HIV-, TB- and malaria-specific imm ...
Voir le projet

 23

 TERMINÉ 

ADVANZ - Advocacy for the fight against Neglected Zoonotic Diseases (ADVANZ)

Date du début: 1 oct. 2012, Date de fin: 31 mars 2015,

"The aim of ADVANZ (Advocacy for Neglected Zoonotic Diseases) is to persuade decision makers and empower stakeholders at local, regional, and international levels towards a coordinated fight against neglected zoonotic diseases (NZD), first and foremost in Africa, where the burden from NZD are heaviest. If the battle against NZD is going to be won, a major part of the initiative must come through a ...
Voir le projet

 6

 TERMINÉ 

Consortium for Health Policy and Systems Analysis in Africa (CHEPSAA)

Date du début: 1 févr. 2011, Date de fin: 31 janv. 2015,

In sub-Saharan Africa health improvement remains a major development challenge. A growing evidence base demonstrates that health systems must be strengthened to secure progress in addressing mortality and tackling disease burdens. Yet there is a dearth of African research to support such action. African Ministers of Health and international agencies have, therefore, called for accelerated developm ...
Voir le projet

 11

 TERMINÉ 

Urban Reduction of GHG Emissions in China and Europe (URGENCHE)

Date du début: 1 sept. 2011, Date de fin: 31 déc. 2014,

In URGENCHE, a team of internationally recognised scientists in the areas of health risk assessment, urban energy demand and supply scenarios, urban planning, environmental science and epidemiology - in close collaboration with city partners in both Europe and China - develops and applies a methodological framework for the assessment of the overall risks and benefits of alternative greenhouse gas ...
Voir le projet

 19

 TERMINÉ 
Vaccine development is an empirical process (trial and error) and involves a long, expensive clinical development pipeline to license an efficacious vaccine candidate. Better tools for vaccine evaluation are needed to adapt to a rising number of candidate vaccines entering clinical trials for many diseases. Surrogate biomarkers of immunity offer the possibility of expediting the clinical developme ...
Voir le projet

 8

 TERMINÉ 

Genome-driven vaccine development for bacterial infections (GENDRIVAX)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,

The aim of the GENDRIVAX (GENome-DRIVen Vaccine) scientific programme is to develop novel prophylactic vaccines against invasive bacterial diseases caused by Salmonella and Neisseria. GENDRIVAX intends to combine the results of recent industrial research (novel platform technologies for producing highly affordable outer membrane antigen based vaccines for Gram-negative bacteria) with the detailed ...
Voir le projet

 4

 TERMINÉ 

African Programme for Advanced Research Epidemiology Training (APARET)

Date du début: 1 avr. 2011, Date de fin: 31 déc. 2014,

The APARET fellowship programme will catalyse independent research activities of graduates of Field Epidemiology Training Programmes (FETP) and Field Epidemiology Laboratory Training programmes (FELTP) in Africa. APARET fellows will be employed as research associates by African APARET partners for 2 years (salary provided by host institute). During the first year of their contract they will be emb ...
Voir le projet

 13

 TERMINÉ 
"This project aims at Improving Human Health and Animal Production in developing countries through Integrated Control of Neglected Zoonoses in animals, based on Scientific Innovation and Public Engagement. Neglected zoonoses, such as anthrax, rabies, brucellosis, bovine TB, zoonotic trypanosomiasis, echinococcosis, cysticercosis and leishmaniasis, are major causes of ill-health in developing coun ...
Voir le projet

 23

 TERMINÉ 
TRANSPHORM brings together leading air quality and health researchers and users to improve the knowledge of transport related airborne particulate matter (PM) and its impact on human health and to develop and implement assessment tools for scales ranging from city to Europe. Over four years, TRANSPHORM will aim to develop and implement an integrated methodology to assess the health impacts of PM a ...
Voir le projet

 21

 TERMINÉ 

Accessing Medicines in Africa and South Asia (AMASA)

Date du début: 1 mai 2010, Date de fin: 31 oct. 2013,

"The main aim of the proposed research is to investigate how the interplay of patent regimes, pharmaceutical regulation, availability of drug production facilities, health care infrastructure and service provision, and engagement by foreign donors influence appropriate, affordable access to medicines in South Asia and Sub-Saharan Africa. We aim to map patterns of production, distribution, supply a ...
Voir le projet

 8

 TERMINÉ 
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, is a neglected bacterial infection of the poor in remote rural areas, mostly affecting children. BUD, the third most common mycobacterial disease in immunocompetent humans after tuberculosis and leprosy, is most endemic in West Africa, but cases have been reported from more than 30 countries. BUD is a mutilating disease leading to sever ...
Voir le projet

 16

 TERMINÉ 

EO in Malaria Vector Control and Management (MALAREO)

Date du début: 1 févr. 2011, Date de fin: 31 janv. 2013,

"“In Africa today, malaria is understood to be both a disease of poverty and a cause of poverty."" Nevertheless, malaria is a preventable and curable disease. According to the Abuja declaration, the goal is to halve malaria mortality in Africa by 2010.” (WHO, 2008, Status Report on Malaria in the African region). This report also states that most of the African countries within the region are atte ...
Voir le projet

 6

 TERMINÉ 

Nucleobase derivatives as drugs against trypanosomal diseases (trypobase)

Date du début: 1 janv. 2009, Date de fin: 30 juin 2012,

The protozoan diseases, leishmaniasis, African trypanosomiasis and Chagas’ disease are responsible for substantial global morbidity, mortality, and economic adversity, and in most countries, existing strategies for control and treatment are either failing or under serious threat. New tools for combating pathogenic protozoa and the development and exploitation of new drug targets are required. This ...
Voir le projet

 7

 TERMINÉ 

European Network on Noise And Health (ENNAH)

Date du début: 1 sept. 2009, Date de fin: 31 janv. 2012,

"This proposal puts forward plans to establish a research network of experts on noise and health in Europe. This network will establish future research directions and policy needs in Europe. The network will review the existing literature on environmental noise exposure and health focussing on the consolidation of existing state of the art knowledge and the identification of gaps in the evidence a ...
Voir le projet

 37